Daily Intelligence Brief
Suboxone Drives a Firm-Weighted Filing Surge
Suboxone Film Products Liability Litigation (3092) dominated the day’s intake with 130 filings, led by Nigh Goldenberg Raso Vaughn PLLC. Bard Implanted Port Catheter Products Liability Litigation (3081) followed with 30 complaints as Simmons Hanly Conroy LLP filed eight and Roman Balaban & Associates LLC filed five, concentrating the device docket’s next tier. Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) added 11 cases, led by Singleton Schreiber LLP’s three and Wallace Miller’s two. Platform and legacy-drug activity finished the top tier: Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) received 10 filings from Keller Postman LLC and Lieff Cabraser, while Zantac Products Liability Litigation (2924) logged seven, all from Keller Postman LLC. See the full filing feed and firm-level breakdowns here.
Semaglutide NAION Report Focuses Causation Inquiry
An August 3 online case report proposed a two-hit model for semaglutide-associated non-arteritic anterior ischemic optic neuropathy, putting anatomical susceptibility and sustained hypohydration at the center of Glucagon-like Peptide-1 Receptor Agonists Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation (3163). The report described a 28-year-old man who developed right NAION four to five months after starting semaglutide, with imaging showing bilateral buried optic disc drusen and serial measurements showing a 1.9-liter decline in total body water. The account is hypothesis-generating rather than proof of product causation, but it gives counsel a concrete alternative-causation framework as expert opinions develop. Plaintiffs will need to distinguish an alleged drug effect from claimant-specific anatomy and hydration history, while defendants will press those factors as competing explanations.
Study Cuts Against Simple Screen-Time Theory
An August 3 longitudinal publication cut against a simple screen-time theory in Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047), finding no main association between time spent on social media and internalizing problems at ages 15 or 18. Problematic social-media use, however, was consistently associated with more internalizing problems cross-sectionally and showed a small longitudinal association driven primarily by girls. The distinction gives defendants current support to challenge opinions that equate exposure time with injury, while preserving a narrower inquiry into compulsive-use evidence. Plaintiffs will need to connect platform design and each claimant’s usage pattern to the alleged mental-health harm rather than rely on raw hours online.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.